Literature DB >> 892366

Transient neutropenia in a patient receiving cimetidine.

M H Ufberg, C M Brooks, P R Bosanac, J E Kintzel.   

Abstract

Transient neutropenia developed in a 62-year-old, white male on maintenance hemodialysis being treated with cimetidine for an in tractable duodenal ulcer. The probable mechanism was peripheral destruction of the granulocyte series, unlike the marrow depression reported with metiamide, another histamine H2 receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892366

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Haematological adverse effects of histamine H2-receptor antagonists.

Authors:  J P Aymard; B Aymard; P Netter; B Bannwarth; P Trechot; F Streiff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Cimetidine-associated thrombocytopenia and leukopenia.

Authors:  M J Collen
Journal:  West J Med       Date:  1980-03

3.  Fever, abdominal pain, and leucopenia during treatment with cimetidine.

Authors:  C L Corbett; C D Holdsworth
Journal:  Br Med J       Date:  1978-03-25

4.  Cimetidine-induced bone marrow suppression.

Authors:  E A Pariente; O Nouel
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

5.  Cimetidine and cytopenia.

Authors:  H P Selker; B E Rosenbloom; I M Weinstein
Journal:  West J Med       Date:  1981-10

6.  Adverse effects of anti-ulcer drugs.

Authors:  D A Henry; M J Langman
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

7.  Association of cimetidine and bone-marrow suppression in man.

Authors:  F Druart; C Frocrain; P Metois; J Martin; C Matuchansky
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

8.  Cimetidine and hematologic suppression: things are not always as they appear.

Authors:  J E Richter; D C Gerhardt; D N Pasquale; D O Castell
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

Review 9.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

10.  The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.

Authors:  J A Ziemniak; B M Assael; R Padoan; J J Schentag
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.